Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease

NCT06780241 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT06780241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06780241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease
Lead sponsor
The Cleveland Clinic
Phase
Observational
Overall status
Recruiting
Start date
December 10, 2024
Completion date
December 31, 2030
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic regurgitation, aortic stenosis, mitral regurgitation